Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ankyrin repeat domain is a common structural motif consisting of approximately 33 amino acids that typically mediates protein–protein interactions and forms a linear solenoid structure built from tandem repeats. Proteins containing ankyrin repeat domains serve in a wide variety of cellular processes, including cell cycle regulation, cytoskeletal organization, signal transduction, and epigenetic regulation. The term "ankyrin repeat domain 16" can refer to a specific protein, ANKRD16, or generically to any 16th ankyrin repeat-containing domain, but as a drug target, it lacks specific characterization and is not recognized as a canonical therapeutic receptor, enzyme, transporter, or biomarker. If your query refers to the broad structural motif rather than a specific protein, it is not a conventional therapeutic target and should not be considered as such. If you mean the gene/protein ANKRD16 (ankyrin repeat domain-containing protein 16), this is a single human protein with unclear disease relevance and no established targeting drugs, although it may be involved in general protein–protein interaction networks.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 16 (ANKRD16).